Document is current
Any future updates will be listed below
-
Authors
Olthof, Pim B.
Bouwense, Stefan A. W.
Bednarsch, Jan
Dewulf, Maxime
Kazemier, Geert
Maithel, Shishir
Jarnagin, William R.
Aldrighetti, Luca
Roberts, Keith J.
Troisi, Roberto I.
Malago, Massimo M.
Lang, Hauke
Alikhanov, Ruslan
Ruzzenente, Andrea
Malik, Hassan
Charco, Ramón
Sparrelid, Ernesto
Pratschke, Johann
Cescon, Matteo
Nadalin, Silvio
Hagendoorn, Jeroen
Schadde, Erik
Hoogwater, Frederik J. H.
Schnitzbauer, Andreas A.
Topal, Baki
Lodge, Peter
Olde Damink, Steven W. M.
Neumann, Ulf P.
Groot Koerkamp, Bas
,
Bartlett Dm Bartsch, F.
Bechstein, W. O.
Bednarsch, J.
Benzing, C.
de Boer, M. T.
Buettner, S.
Capobianco, I.
D’Angelica, M. I.
de Reuver, P.
de Savornin Lohman, E.
Dopazo, C.
Efanov, M.
Erdmann, J. I.
Franken, L. C.
Geers, J.
Giglio, M. C.
Gilg, S.
Gomez-Gavara, C.
Guglielmi, A.
van Gulik, T. M.
Hakeem, A.
Heil, J.
Jansson, H.
Kingham, T. P.
Maithel, S. K
Margies, R.
Marino, R.
Molenaar, Q. I.
Nguyen, T. A.
Nooijen, L. E.
Nota, C. L. M.
Poletto, E.
Porte, R. J.
Prasad, R.
Quinn, L. M.
Ratti, F.
Ravaioli, M.
Rolinger, J.
Schmelzle, M.
Serenari, M.
Sultana, A.
Sutcliff, R.
Topal, H.
van Laarhoven, S.
Zonderhuis, B. M.
- License Information
-
More Information
Article History
Received: 29 July 2024
Accepted: 17 September 2024
First Online: 15 October 2024
Disclosures
: Ulf Neumann presented for Astra Zeneca, Roche AG, Merck AG, and Dr Falk GMBH, BMS. No other conflicts of interest are present. Data available upon reasonable request.
